Individuals with ACTH secreting microadenomas have a higher incidence of hypothyroidism and should be evaluated. This only makes physiologic sense, knowing the impact on 5'deiodinase, and TSH production.
Also of importance, is the methodology of cortisol evaluation. They used salivary cortisol levels to follow. This study was conducted at John Hopkins school of Medicine, Division of Endocrinology. Some how others here in Louisiana have missed this (Namely LSBME and BCBS).
Moderate resistance training program over 8 weeks associated with increased Testosterone production in young and middle age lean men. Growth hormone was also increased in both groups. ACTH and cortisol decreased in this lean men.
Individuals with Fibromyalgia shown to have lowered salivary cortisol levels. This study suggested that this could be due to reduced adrenal reactivity to ACTH. Another thought, is there increased metabolism of cortisol in these clients. This would be found in the urinary metabolites.
Low cortisol found in those with PTSD. This study suggest the high ACTH/cortisol ratio is not due to enhanced peripheral sensitization to glucocorticoids.
Stress response in a animal model is blunted at the level of pituitary through a decrease in ACTH release and through increase in peripheral metabolism
cortisol may act as a mineralocorticoid when in excess, perhaps by saturating the 11β-hydroxysteroid-dehydrogenase (11β-HSD2 enzyme) that inactivates cortisol at the renal tubule
high cortisol levels may be the principal cause of hypokalemic alkalosis
Sex steroid hormones are primarily responsible for sex difference in adult HPA function; androgens inhibit whereas estrogens
enhance HPA axis activation after a stressor
the PVN contains relatively high levels of AR (Bingaman et al., 1994; Zhou et al., 1994) and ERβ (Alves et al., 1998; Hrabovszky et al., 1998; Somponpun and Sladek, 2003) but is essentially devoid of ERα
the nonaromatizable androgen DHT and the nonselective ER ligand E2 influence HPA
reactivity by acting on neurons within or surrounding the PVN
inhibitory action of DHT is detectable at both the level
of hormone secretion as well as PVN c-fos mRNA expression
the inhibition can be mimicked by the DHT metabolite
3β-diol and by the subtype selective ERβ agonist DPN
E2 acts to enhance HPA reactivity
the ability of the ER antagonist tamoxifen, but
not the AR antagonist flutamide, to block the inhibitory actions of DHT, speaks to the intracellular mechanism by which this
inhibitory signal might be transduced.
that is because the interaction with the DHT metabolite is not with the AR, but with the ER-beta.
the DHT metabolite 3β-diol and the ERβ-subtype-selective agonist DPN suppressed ACTH, corticosterone, and c-fos
mRNA responses to restraint stress in a manner similar to DHT
metabolism of DHT to
3β-diol and subsequent binding to ERβ can be inhibitory to HPA reactivity, and this is one possible mechanism for the action
of DHT.
Our data also suggest that E2 enhances the reactivity of the HPA axis to stress by acting on or near neurons of the PVN
the actions of E2 appear to be through an ERα-dependent mechanism
these studies suggest that ERβ, within the male hypothalamus, acts to inhibit the HPA axis and that the inhibitory
effects of DHT may be, at least in part, via its intracellular conversion to 3β-diol and subsequent binding to ERβ
psychobiological mechanisms, which trigger the hypothalamus-pituitary-adrenal axis (HPAA) can only indirectly be assessed by salivary cortisol measures. The different instances that control HPAA reactivity (hippocampus, hypothalamus, pituitary, adrenals) and their respective modulators, receptors, or binding proteins, may all affect salivary cortisol measures.
linear relationship with measures of plasma ACTH and cortisol in blood or urine does not necessarily exist
Four studies have reported that the probability of GHD (peak GH criteria ranging from < 2.3 to < 5 μg/liter) in patients with three to four PHDs ranges from 91% to 100%
95% accuracy by the presence of either three or more PHDs or a serum IGF-I concentration less than 84 μg/lite
adult GHD could be predicted with 95% accuracy by the presence of either three or four PHDs or a serum IGF-I concentration less than 84 μg/liter
Hypopituitary adults with GHD have been reported to have normal serum IGF-I levels in 37–70% of patients in various studies (5, 9, 18, 21, 22). This is owing in part to the fact that multiple factors regulate serum IGF-I concentrations including nutritional status; hepatic and renal function; and circulating concentrations of thyroid hormone, androgens, and estrogens
changes in concentrations of IGF-binding proteins (IGFBPs) influence the total concentration of IGF-I in plasma
Among patients with an IGF-I sd score above −1 in the present study, 46% had a peak GH less than 2.5 μg/liter and 67% had a peak GH less than 5 μg/liter.
In summary, adult GHD can be predicted with 95% accuracy by the presence of either three or four PHDs or a serum IGF-I concentration less than 84 μg/liter
We propose that adult patients with three or four PHDs (three or four of the following deficiencies: TSH, ACTH, gonadotropins [LH and/or FSH], and AVP [central diabetes insipidus]) do not require a GH stimulation test to make the diagnosis of adult GHD
Insulin Tolerance Test is the gold standard for HGH diagnosis, but this an unpopular test do to long list of side effects. This study finds a 95% accuracy for IGF-1 less than 84 with 3 or more coexisting pituitary hormone deficiencies.
Good case review of secondary adrenal insufficiency. A common cause of low sodium and needs to be considered in elderly patients. Also, low cortisol is associated with increased ADH. In the case of adrenal insufficiency, the negative feed back of cortisol to the HPA is lost and recreation of CRH, which is an ADH secretagogue, will increase ADH secretion.
facilitates the transport of intra and extra cellular liquids which helps the organism to eliminate the toxic products
The increased number of insulin receptors on the tumor cell, in comparison to the normal one, allows the before mentioned 2 factors to act predominantly
Increased permeability after the insulin effect on the cellular membrane results in increased intracellular quantity of antitumor agents
have other endocrine effects: directly stimulates suprarenal gland to produce epinephrine and glucocorticoid hormones and stimulates ACTH secretion. These endocrine effects also have a positive influence on the regenerating processes
Insulin influences the intracellular metabolism of the tumor cell, which leads to increase of the number of cells in phase S, where they are with highly sensitive to specific chemotherapeutics.
After the first 6 IPT applications overall (groups A and B) response to treatment on PSA criteria shows partial effect and stabilization in 12 of 16 (75%) patients
After the 10th IPTLD application or 3 months after starting treatment, complete response, partial response, and stabilization were observed in 4 of 9 (66.6%), while in 3 of 9 (33.3%) was registered complete effect
the advanced stage of disease in patients treated
Quality of life after the second IPTLD application is significantly improved